Beijing Tong Ren Tang Chinese Medicine Co (HK:3613) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Beijing Tong Ren Tang Chinese Medicine Company Limited has released its unaudited interim results for the first half of 2024, which are now available for shareholders and interested parties. The report, in compliance with the Hong Kong Stock Exchange listing rules, will be accessible both in print and on the company’s website by September 30, 2024. These results reflect the latest financial performance of the company and its subsidiaries.
For further insights into HK:3613 stock, check out TipRanks’ Stock Analysis page.